IGHE and plasma cell myeloma: There was, however, some controversy over which tumour types were more prevalent in the IgE-deficient group, with Ferastraoaru and colleagues (2017) noting an increased prevalence of lymphoma and multiple myeloma in the IgE-deficient cohort, supporting previous findings from other groups [106,107,108].